Olah J - Search Results

1

Leptin-based glycopeptide induces weight loss and simultaneously restores fertility in animal models.

Kovalszky I, Surmacz E, Scolaro L, Cassone M, Ferla R, Sztodola A, Olah J, Hatfield MP, Lovas S, Otvos L Jr. Kovalszky I, et al. Among authors: olah j. Diabetes Obes Metab. 2010 May;12(5):393-402. doi: 10.1111/j.1463-1326.2009.01170.x. Diabetes Obes Metab. 2010. PMID: 20415687

2

Peptide-based leptin receptor antagonists for cancer treatment and appetite regulation.

Otvos L Jr, Kovalszky I, Scolaro L, Sztodola A, Olah J, Cassone M, Knappe D, Hoffmann R, Lovas S, Hatfield MP, Beko G, Zhang S, Wade JD, Surmacz E. Otvos L Jr, et al. Among authors: olah j. Biopolymers. 2011;96(2):117-25. doi: 10.1002/bip.21377. Biopolymers. 2011. PMID: 20564005

3

Optimization of adiponectin-derived peptides for inhibition of cancer cell growth and signaling.

Otvos L Jr, Kovalszky I, Olah J, Coroniti R, Knappe D, Nollmann FI, Hoffmann R, Wade JD, Lovas S, Surmacz E. Otvos L Jr, et al. Among authors: olah j. Biopolymers. 2015 May;104(3):156-66. doi: 10.1002/bip.22627. Biopolymers. 2015. PMID: 25683126

4

Efficacy of a leptin receptor antagonist peptide in a mouse model of triple-negative breast cancer.

Otvos L Jr, Kovalszky I, Riolfi M, Ferla R, Olah J, Sztodola A, Nama K, Molino A, Piubello Q, Wade JD, Surmacz E. Otvos L Jr, et al. Among authors: olah j. Eur J Cancer. 2011 Jul;47(10):1578-84. doi: 10.1016/j.ejca.2011.01.018. Epub 2011 Feb 23. Eur J Cancer. 2011. PMID: 21353530

5

Development of second generation peptides modulating cellular adiponectin receptor responses.

Otvos L Jr, Knappe D, Hoffmann R, Kovalszky I, Olah J, Hewitson TD, Stawikowska R, Stawikowski M, Cudic P, Lin F, Wade JD, Surmacz E, Lovas S. Otvos L Jr, et al. Among authors: olah j. Front Chem. 2014 Oct 17;2:93. doi: 10.3389/fchem.2014.00093. eCollection 2014. Front Chem. 2014. PMID: 25368867 Free PMC article.

6

Characterisation of bioenergetic pathways and related regulators by multiple assays in human tumour cells.

Jeney A, Hujber Z, Szoboszlai N, Fullár A, Oláh J, Pap É, Márk Á, Kriston C, Kralovánszky J, Kovalszky I, Vékey K, Sebestyén A. Jeney A, et al. Among authors: olah j. Cancer Cell Int. 2016 Feb 11;16:4. doi: 10.1186/s12935-016-0281-x. eCollection 2016. Cancer Cell Int. 2016. PMID: 26869854 Free PMC article.

7

[Potentiation of 5-fluorouracil efficacy. Molecular mechanisms playing a role in the cytotoxic action of 5-fluorouracil and 5-ethyl-2'-deoxyuridine (EUdR) combination].

Katona C, Timár F, Oláh J, Bocsi J, Budai B, Otvös L, Kralovánszky J. Katona C, et al. Among authors: olah j. Magy Onkol. 2004;48(3):243-51. Epub 2004 Nov 1. Magy Onkol. 2004. PMID: 15520875 Free article. Hungarian.

8

Repopulation of osteosarcoma cells after treatment with doxorubicin in the presence of extracellular matrix biopolymers.

Harisi R, Dudás J, Pogány G, Timár F, Oláh JN, Szendroi M, Jeney A. Harisi R, et al. Among authors: olah jn. Cancer Chemother Pharmacol. 2006 Sep;58(3):334-42. doi: 10.1007/s00280-005-0165-6. Epub 2006 Mar 14. Cancer Chemother Pharmacol. 2006. PMID: 16534616

9

The antiproliferative action of a melphalan hexapeptide with collagenase-cleavable site.

Timár F, Botyánszki J, Süli-Vargha H, Babó I, Oláh J, Pogány G, Jeney A. Timár F, et al. Among authors: olah j. Cancer Chemother Pharmacol. 1998;41(4):292-8. doi: 10.1007/s002800050742. Cancer Chemother Pharmacol. 1998. PMID: 9488598

10

Differential inhibition of single and cluster type tumor cell migration.

Harisi R, Kenessey I, Olah JN, Timar F, Babo I, Pogany G, Paku S, Jeney A. Harisi R, et al. Anticancer Res. 2009 Aug;29(8):2981-5. Anticancer Res. 2009. PMID: 19661304 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

287 results

Search Page

Filters